These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2824675)
1. Antibodies to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control groups. Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Lee HH; Kuo SL J Med Virol; 1987 Sep; 23(1):11-21. PubMed ID: 2824675 [TBL] [Abstract][Full Text] [Related]
2. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Beasley RP; Hwang LY J Med Virol; 1989 Apr; 27(4):269-73. PubMed ID: 2542436 [TBL] [Abstract][Full Text] [Related]
3. Antibody response to Epstein-Barr-virus-specific DNase in 13 patients with nasopharyngeal carcinoma in Taiwan: a retrospective study. Chen JY; Hwang LY; Beasley RP; Chien CS; Yang CS J Med Virol; 1985 Jun; 16(2):99-105. PubMed ID: 2989423 [TBL] [Abstract][Full Text] [Related]
4. Antibody to Epstein-Barr virus specific DNase in sera of nasopharyngeal carcinoma and other nine most common cancer patients in Taiwan. Hsu MM; Chen JY; Liu MY; Lynn TC; Tu SM; Yang CS Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Aug; 17(3):131-7. PubMed ID: 6096088 [TBL] [Abstract][Full Text] [Related]
5. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma. Chen JY; Liu MY; Chen CJ; Hsu MM; Tu SM; Lee HH; Kuo SL; Yang CS J Med Virol; 1985 Sep; 17(1):47-9. PubMed ID: 2995572 [TBL] [Abstract][Full Text] [Related]
6. Antibody to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma. Chen JY; Liu MY; Lynn TC; Yang CS Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Nov; 15(4):255-61. PubMed ID: 6305599 [TBL] [Abstract][Full Text] [Related]
7. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma. Cheng YC; Chen JY; Glaser R; Henle W Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6162-5. PubMed ID: 6255477 [TBL] [Abstract][Full Text] [Related]
8. Antibody responses to Epstein-Barr virus-specific DNase in relation to the prognosis of juvenile patients with nasopharyngeal carcinoma. Tan RS; Cheng YC; Naegele RF; Henle W; Glaser R; Champion J Int J Cancer; 1982 Nov; 30(5):561-5. PubMed ID: 6295964 [TBL] [Abstract][Full Text] [Related]
10. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma. Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519 [TBL] [Abstract][Full Text] [Related]
11. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibody to Epstein-Barr virus DNase in children. Liu MY; Cho SM; Tsai WS; Chang MH; Chen JY; Yang CS Intervirology; 1992; 34(4):192-6. PubMed ID: 1339186 [TBL] [Abstract][Full Text] [Related]
13. Use of bacterially-expressed antigen for detection of antibodies to the EBV-specific deoxyribonuclease in sera from patients with nasopharyngeal carcinoma. Chen JY; Liu MY; Hsu TY; Cho SM; Yang CS J Virol Methods; 1993 Nov; 45(1):49-66. PubMed ID: 8270655 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups. Lin TM; Yang CS; Chiou JF; Tu SM; Chen TY; Tu YC; Lin PJ; Kawamura A; Hirayama T Am J Epidemiol; 1977 Oct; 106(4):336-9. PubMed ID: 199059 [TBL] [Abstract][Full Text] [Related]
15. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma. Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902 [TBL] [Abstract][Full Text] [Related]
16. Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan. Yang X; Goldstein AM; Chen CJ; Rabkin CS; Chen JY; Cheng YJ; Hsu WL; Sun B; Diehl SR; Liu MY; Walters M; Shao W; Ortiz-Conde BA; Whitby D; Elmore SH; Gulley ML; Hildesheim A Int J Cancer; 2006 Feb; 118(3):780-4. PubMed ID: 16106400 [TBL] [Abstract][Full Text] [Related]
17. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma. Luo YL; Ou GP; Chi PD; Liang YN; Liu YH; Huang MY Ai Zheng; 2009 Jan; 28(1):76-8. PubMed ID: 19448423 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Ho HC; Ng MH; Kwan HC; Chau JC Br J Cancer; 1976 Dec; 34(6):655-60. PubMed ID: 188437 [TBL] [Abstract][Full Text] [Related]
19. Expression of the DNase encoded by the BGLF5 gene of Epstein-Barr virus in nasopharyngeal carcinoma epithelial cells. Sbih-Lammali F; Berger F; Busson P; Ooka T Virology; 1996 Aug; 222(1):64-74. PubMed ID: 8806488 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome. Jones JF; Williams M; Schooley RT; Robinson C; Glaser R Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]